Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
19 hedge funds and large institutions have $1.14M invested in Bio-Path Holdings Inc in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and closing their positions.
19% more funds holding
Funds holding: 16 → 19 (+3)
29% less capital invested
Capital invested by funds: $1.61M → $1.14M (-$473K)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$14K |
| 2 |
HI
Human Investing
Lake Oswego,
Oregon
|
+$10.4K |
| 3 |
PA
Procyon Advisors
Shelton,
Connecticut
|
+$7.78K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$104 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$104 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$567K |
| 2 |
Renaissance Technologies
New York
|
-$84.7K |
| 3 |
BlackRock
New York
|
-$49.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.36K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$7.05K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $302K | -$49.5K | -477 | -14% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $227K | -$567K | -5,465 | -71% |
|
|
3
Renaissance Technologies
New York
| $225K | -$84.7K | -817 | -27% |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $184K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $103K | – | – | – |
|
6
Bank of Montreal
Toronto,
Ontario, Canada
| $52K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $14K | +$14K | +135 | New |
|
|
PA
8
Procyon Advisors
Shelton,
Connecticut
| $13K | +$7.78K | +75 | +150% |
|
|
HI
9
Human Investing
Lake Oswego,
Oregon
| $10K | +$10.4K | +100 | New |
|
10
Morgan Stanley
New York
| $5K | -$3.94K | -38 | -43% |
|
|
11
UBS Group
Zurich,
Switzerland
| $3K | -$7.36K | -71 | -68% |
|
|
12
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$104 | +1 | +17% |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$7.05K | -68 | -99% |
|
14
Wells Fargo
San Francisco,
California
| – | -$207 | -2 | -67% |
|
|
15
Osaic Holdings
Scottsdale,
Arizona
| – | +$104 | +1 | New |
|
BPTH Hedge Fund Activity: Q2 2020 in Review
19 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2020, worth a combined $1.14M — down 29% from $1.61M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BPTH positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 7 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $14K. The largest seller was Sabby Management, cutting an estimated $567K.
- 19 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2020, up from 16 in Q1 2020.
- Funds reported $1.14M of Bio-Path Holdings Inc stock for Q2 2020, down 29% quarter-over-quarter.
- 3 funds opened new Bio-Path Holdings Inc positions in Q2 2020 and 0 closed out, a net change of +3 holders.
- The largest Bio-Path Holdings Inc buyer in Q2 2020 was Tower Research Capital (TRC), an estimated $14K added.
- The largest Bio-Path Holdings Inc seller in Q2 2020 was Sabby Management, an estimated $567K sold.
Based on aggregated 13F filings for Q2 2020.